MedPlus Health Services Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, MedPlus Health Services stock has a consensus rating of "Strong Buy" and an average price target of ₹1,169. The average 1-year stock price forecast is 40.64% higher than the current stock price, while the lowest is ₹1,100 (+32.37%) and the highest is ₹1,271 (+52.95%).

Price Target: ₹1,169 (+40.64%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	₹1,100	₹1,169	₹1,150	₹1,271
Change	+32.37%	+40.64%	+38.39%	+52.95%

* Price targets were last updated on Feb 11, 2026.

Analyst Ratings

The average analyst rating for MedPlus Health Services stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Jan '26	Feb '26	Apr '26	May '26
Strong Buy	5	5	5	5	5	6
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Keynote Capitals No rating	Keynote Capitals	Buy Maintains ₹1,155	Buy	Maintains	₹1,155	+38.99%	Feb 11, 2026

Financial Forecast

Revenue This Year

78.27B

from 68.92B

13.55%

from 68.92B

Revenue Next Year

90.56B

from 78.27B

15.71%

from 78.27B

EPS This Year

21.72

from 18.29

18.75%

from 18.29

EPS Next Year

25.54

from 21.72

17.61%

from 21.72

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	37.79B	45.58B	56.25B	61.36B	68.92B	78.27B
Revenue Growth	23.13%	20.59%	23.42%	9.09%	12.33%	13.55%
Gross Profit	7.85B	9.82B	12.14B	14.70B	18.08B	20.80B
Gross Margin	20.78%	21.54%	21.59%	23.96%	26.23%	26.58%
Operating Income	1.63B	960.92M	1.42B	2.50B	3.24B	4.09B
Net Income	958.02M	497.63M	654.73M	1.50B	2.20B	2.59B
EPS	-	-	-	-	18.29	21.72
EPS Growth	-	-	-	-	46.09%	18.75%
Forward PE	82.82	101.15	83.56	48.95	42.61	38.26
Free Cash Flow	-6.06B	4.38B	389.73M	3.69B	2.72B	4.67B
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	80.6B
Avg	78.3B
Low	75.6B

Revenue Growth

Revenue Growth	2027	2028	2029
High	16.9%
Avg	13.6%
Low	9.7%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	21.72
Low	-

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	18.8%
Low	-